Preoperative Localization Strategies in Primary Hyperparathyroidism

NACompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Primary Hyperparathyroidism
Interventions
PROCEDURE

Contrast-enhanced ultrasound

"Ultrasound contrast agent: Stabilized sulfur hexafluoride microbubbles (SonoVue®, Bracco).~An 18 G needle will be placed in an antecubital vein and directly attached to a three-way stopcock with an extension tube.~The SonoVue® will be prepared and shaken shortly before injection in accordance with the instructions provided in the product information leaflet.~The patient will be injected with 1.2 ml SonoVue® at a pace of 1-2 ml/s using the 180 degree straight-flow channel of the three-way stopcock, directly followed by a 10 ml bolus of sodium chloride 9 mg/mL (0.9%) injected into the 90 degree channel of the three-way stopcock at a pace of approximately 2 ml/s.~A full examination will typically require one to two injections of 1.2 ml of SonoVue® (one injection per suspected parathyroid adenoma)."

Trial Locations (1)

5000

Odense University Hospital, Odense C

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT04305561 - Preoperative Localization Strategies in Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter